Hidoc Dr | Medical Learning App for Doctors

Today's Updates

AAN Publishes First-Ever Guideline for Functional Seizure Care Management Marco Meglio

Published Date: 03 Feb 2026

The AAN's new guideline enhances diagnosis and management of functional seizures, emphasizing psychological interventions and addressing care gaps for better patient outcomes.

NeurologyLive® Friday 5 — January 30, 2026 Isabella Ciccone, MPH

Published Date: 03 Feb 2026

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending January 30, 2026.

Navigating Autoimmune Overlap in Celiac Disease, With Daniel Mallon, MD Daniel Mallon, MD

Published Date: 03 Feb 2026

Mallon explains the shared risks linking celiac disease and type 1 diabetes and why early screening improves outcomes.

Unraveling the Complexities of Concomitant IBD and Hepatobiliary Disease, With Natalia Nedelkopoulou, MD Natalia Nedelkopoulou, MD

Published Date: 03 Feb 2026

Nedelkopoulou emphasizes the importance of structured and multidisciplinary transition programs for young patients with IBD and HPB disease.

FDA Accepts Oxylanthanum Carbonate NDA Resubmission for Hyperphosphatemia in CKD, Dialysis

Published Date: 03 Feb 2026

FDA Accepts Oxylanthanum Carbonate NDA Resubmission for Hyperphosphatemia in CKD, Dialysis

6 Nephrology Headlines You Missed In January 2026

Published Date: 03 Feb 2026

6 Nephrology Headlines You Missed In January 2026

OptIMMize-1: New Efficacy and Safety Data on Risankizumab in Pediatric Psoriasis

Published Date: 03 Feb 2026

OptIMMize-1: New Efficacy and Safety Data on Risankizumab in Pediatric Psoriasis

Positive Topline Data Released on Roflumilast Cream in Infants with Atopic Dermatitis

Published Date: 03 Feb 2026

Positive Topline Data Released on Roflumilast Cream in Infants with Atopic Dermatitis

FDA Accepts Resubmitted BLA for RelabotulinumtoxinA for Glabellar and Lateral Canthal Lines

Published Date: 03 Feb 2026

FDA Accepts Resubmitted BLA for RelabotulinumtoxinA for Glabellar and Lateral Canthal Lines

Knowledge Hub

Oncology

Giant Sebaceous Cyst of the Scalp Mimicking a Soft Tissue Tumor: A Case Study

A rare giant sebaceous cyst of the scalp presenting as a soft tissue tumor case study.

Oncology

Theranostics and Radioligand Therapy: Precision Cancer Care with Targeted Radionuclides

Precision cancer care using theranostics and radioligand therapy enhances targeted treatment and patient outcomes.

Oncology

Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization

Explore strategies for optimizing oncology trials, enhancing recruitment, decentralization, diversity, and patient-centered care.

Oncology

Optimizing Cancer Care: Multidisciplinary Approaches and Supportive Strategies

Enhance cancer care with multidisciplinary strategies, supportive therapies, and patient-centered interventions for better outcomes.

Oncology

KOL Videos

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug Database Drug Interaction Diseases Database

KOL Videos Knowledge Hub Quizzes

Medical Updates Events About Us

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation

Your one-stop Solution for MEDICAL LEARNING & UPDATES

AAN Publishes First-Ever Guideline for Functional Seizure Care Management Marco Meglio

NeurologyLive® Friday 5 — January 30, 2026 Isabella Ciccone, MPH

Navigating Autoimmune Overlap in Celiac Disease, With Daniel Mallon, MD Daniel Mallon, MD

Unraveling the Complexities of Concomitant IBD and Hepatobiliary Disease, With Natalia Nedelkopoulou, MD Natalia Nedelkopoulou, MD

FDA Accepts Oxylanthanum Carbonate NDA Resubmission for Hyperphosphatemia in CKD, Dialysis

6 Nephrology Headlines You Missed In January 2026

OptIMMize-1: New Efficacy and Safety Data on Risankizumab in Pediatric Psoriasis

Positive Topline Data Released on Roflumilast Cream in Infants with Atopic Dermatitis

FDA Accepts Resubmitted BLA for RelabotulinumtoxinA for Glabellar and Lateral Canthal Lines

Knowledge Hub

Giant Sebaceous Cyst of the Scalp Mimicking a Soft Tissue Tumor: A Case Study

Theranostics and Radioligand Therapy: Precision Cancer Care with Targeted Radionuclides

Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization

Optimizing Cancer Care: Multidisciplinary Approaches and Supportive Strategies

The Future of Cancer Care: Genetics, Support Systems, and Emerging Therapies

Managing KRAS Inhibitor Toxicities: Focus on Rash and Beyond

Harnessing Artificial Intelligence in Oncology: Innovations in Diagnosis, Treatment, and Patient Care

KOL Videos

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

Quick Links

Page Views

Your one-stop Solution for MEDICAL LEARNING & UPDATES

AAN Publishes First-Ever Guideline for Functional Seizure Care Management Marco Meglio

NeurologyLive® Friday 5 — January 30, 2026 Isabella Ciccone, MPH

Navigating Autoimmune Overlap in Celiac Disease, With Daniel Mallon, MD Daniel Mallon, MD

Unraveling the Complexities of Concomitant IBD and Hepatobiliary Disease, With Natalia Nedelkopoulou, MD Natalia Nedelkopoulou, MD

FDA Accepts Oxylanthanum Carbonate NDA Resubmission for Hyperphosphatemia in CKD, Dialysis

6 Nephrology Headlines You Missed In January 2026

OptIMMize-1: New Efficacy and Safety Data on Risankizumab in Pediatric Psoriasis

Positive Topline Data Released on Roflumilast Cream in Infants with Atopic Dermatitis

FDA Accepts Resubmitted BLA for RelabotulinumtoxinA for Glabellar and Lateral Canthal Lines

Knowledge Hub

Giant Sebaceous Cyst of the Scalp Mimicking a Soft Tissue Tumor: A Case Study

Theranostics and Radioligand Therapy: Precision Cancer Care with Targeted Radionuclides

Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization

Optimizing Cancer Care: Multidisciplinary Approaches and Supportive Strategies

The Future of Cancer Care: Genetics, Support Systems, and Emerging Therapies

Managing KRAS Inhibitor Toxicities: Focus on Rash and Beyond

Harnessing Artificial Intelligence in Oncology: Innovations in Diagnosis, Treatment, and Patient Care

KOL Videos

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

Quick Links

Verification

Welcome to Hidoc Dr.

Page Views